Pulse Biosciences's total assets for Q1 2026 were $81.62M, a decrease of -15.08% from the previous quarter. PLSE total liabilities were $15.32M for the fiscal quarter, a -0.87% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.